+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

The role of inflammatory and oxidative stress mechanisms in the pathogenesis of Parkinson's disease: focus on astrocytes

The role of inflammatory and oxidative stress mechanisms in the pathogenesis of Parkinson's disease: focus on astrocytes

Molecular Neurobiology 49(1): 28-38

Neuroinflammation plays a key role in the pathogenesis of Parkinson's disease (PD). Epidemiologic, animal, human, and therapeutic studies support the role of oxidative stress and inflammatory cascade in initiation and progression of PD. In Parkinson's disease pathophysiology, activated glia affects neuronal injury and death through production of neurotoxic factors like glutamate, S100B, tumor necrosis factor alpha (TNF-α), prostaglandins, and reactive oxygen and nitrogen species. As disease progresses, inflammatory secretions engage neighboring cells, including astrocytes and endothelial cells, resulting in a vicious cycle of autocrine and paracrine amplification of inflammation leading to neurodegeneration. The exact mechanism of these inflammatory mediators in the disease progression is still poorly understood. In this review, we highlight and discuss the mechanisms of oxidative stress and inflammatory mediators by which they contribute to the disease progression. Particularly, we focus on the altered role of astroglial cells that presumably initiate and execute dopaminergic neurodegeneration in PD. In conclusion, we focus on the molecular mechanism of neurodegeneration, which contributes to the basic understanding of the role of neuroinflammation in PD pathophysiology.

(PDF emailed within 0-6 h: $19.90)

Accession: 056478915

Download citation: RISBibTeXText

PMID: 23783559

DOI: 10.1007/s12035-013-8483-x

Related references

The Role of Inflammatory and Oxidative Stress Mechanisms in the Pathogenesis of Parkinsona s Disease Focus on Astrocytes. 2013

Pathogenesis of Parkinson's disease: oxidative stress, environmental impact factors and inflammatory processes. Neuroscience Bulletin 23(2): 125-130, 2007

Oxidative stress: a role in the pathogenesis of Parkinson's disease. Journal of Neural Transmission. Supplementum 29: 241-249, 1990

Oxidative stress and the pathogenesis of Parkinson's disease. Neurology 47(6 SUPPL. 3): S161-S170, 1996

Neuroinflammation, Oxidative Stress and the Pathogenesis of Parkinson's Disease. Clinical Neuroscience Research 6(5): 261-281, 2007

Oxidative stress and genetics in the pathogenesis of Parkinson's disease. Neurobiology of Disease 7(4): 240-250, 2000

Iron as catalyst for oxidative stress in the pathogenesis of Parkinson's disease?. Life Sciences 65(18-19): 1973-1976, Oct 1, 1999

Activation of α7 nicotinic acetylcholine receptors protects astrocytes against oxidative stress-induced apoptosis: implications for Parkinson's disease. Neuropharmacology 91: 87-96, 2015

Lipid-mediated oxidative stress and inflammation in the pathogenesis of Parkinson's disease. Parkinson's Disease 2011: 247467-247467, 2011

Activated microglia modulate astroglial enzymes involved in oxidative and inflammatory stress and increase the resistance of astrocytes to oxidative stress in vitro. Glia 56(10): 1114-1126, 2008

Oxidative stress: A major pathogenesis and potential therapeutic target of antioxidative agents in Parkinson's disease and Alzheimer's disease. Progress in Neurobiology 147: 1-19, 2016

Oxidative stress-induced signaling pathways implicated in the pathogenesis of Parkinson's disease. Neuromolecular Medicine 16(2): 217-230, 2015

Oxidative stress and Parkinson's disease: mechanisms and perspectives of treatment. Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 115(7): 141-145, 2015

Pathogenesis of alcoholic hepatitis: Role of inflammatory signaling and oxidative stress. World Journal of Hepatology 3(5): 114-117, 2011

Is Oxidative Stress Associated with Activation and Pathogenesis of Inflammatory Bowel Disease?. Journal of Medical Biochemistry 36(4): 341-348, 2018